Klin Farmakol Farm. 2008;22(4):142-144

TREATMENT OF PRETERM LABOR - TOCOLYTICS AND CORTICOSTEROIDS

Zdeněk Hájek
Gynekologicko-porodnická klinika 1. LF UK a VFN v Praze

Using tocolytics and corticosteroids accounts for the basic treatment of preterm labor. The successful of tocolytic therapy is to postpone premature labor for at least 48 hours to induce lung maturition with corticosteroids and to transport mother to the regional centre. Such as treatment means, the essential change in management of preterm births and significantly decreases the mortality and morbidity of the prematurely delivered newborns.

Keywords: Key words: preterm labor, tocolytics, corticosteroids.

Published: January 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hájek Z. TREATMENT OF PRETERM LABOR - TOCOLYTICS AND CORTICOSTEROIDS. Klin Farmakol Farm. 2008;22(4):142-144.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Pracovní konference Sekce Perinatální medicíny při ČGPS, Litoměřice, 2007.
    2. Hagberg H, Mallard C, Jacobsson B. Role of cytokines in preterm labour and brain injury. BJOG: an International Journal of Obstetrics and Gynaecology 2005; 112: 16-18. Go to original source... Go to PubMed...
    3. Simhan HN, Canavan TP. Preterm premature rupture of membranes: diagnosis,evaluation and management strategie.BJOG: an International Journal of Obstetrics and Gynaecology 2005; 112: 32-37. Go to original source... Go to PubMed...
    4. Romero R, Espinoza J, Goncalves LF, et al. The role of inflammation and Infection in Preterm birth, Semin.Reprod.Med. 2007; 25: 21-39. Go to original source... Go to PubMed...
    5. Wang PH: The choice of tocolytic drugs for preterm labor-comparison of COX-2 inhibitor and magnesium sulfate, J: Obstet.Gynaecol.Res. 2008; 34: 439-440. Go to original source... Go to PubMed...
    6. Hájek Z. Terapie předčasného porodu, in: Rizikové a patologické těhotenství (ed. Z. Hájek a kol.), Praha, Grada Publishing, 2004: 272-276.
    7. Grether JK, Hoogstate J, Walshgreen E, et al. Magnesium sulfate for tocolysis and risk of spastic cerebral palsy in premature children born to women without preeclampsia. Am.J.Obstet.Gynecol. 2000; 183: 717-725. Go to original source... Go to PubMed...
    8. Ben-Ami M, Giladi Y, Shalev E. The combination of magnesium sulfate and Nifedipin: A cause of neuromuscular blockage. Br.J.Obstet.Gynaecol. 1994; 101: 262-263. Go to original source... Go to PubMed...
    9. Lees CC, Lojacono A, Thompson C, et al. Glycerintrinitrate and ritodrine in tocolysis: An international multicenter randomized study. Obstet.Gynecol. 1999; 94: 403-408. Go to original source... Go to PubMed...
    10. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the RDS in premature infants, Pediatrics, 1950; 50: 415-525. Go to original source...
    11. Goldenberg RL. The management of Preterm labor, Obstet.Gynecol. 2002; 100: 1020-1037. Go to original source... Go to PubMed...
    12. Baud O, Foix-Helias L, Kaminski M. Antenatal glucocorticoid treatment and cystic perivantricular leukomalacia in very premature infants. N.Engl.J.Med. 1999; 341: 1190-1196. Go to original source... Go to PubMed...
    13. Cumulative perinatal steroids: child development of preterm infants. J.Pediatr.Nurs. 2008; 23: 201-214. Go to original source... Go to PubMed...
    14. Gates EJ, Paul DA, Stahl GE, et al. Effect of corticosteroids on survival for neonates born at 23 weeks of gestation. Obstet.Gynecol. 2008; 111: 921-926. Go to original source... Go to PubMed...
    15. Ventolini G, Neiger R, Mathews L, et al. Incidence of respiratory disorders in neonates born between 34 and 36 weeks of gestation following exposure to antenatal corticosteroids between 24 and 34 weeks of gestation. Am.J.Perinatol. 2008; 25: 75-78. Go to original source... Go to PubMed...
    16. Galik M, Gaspar R, Kolarovszki-Sipiczki Z, et al. Gestagen treatment enhances the tocolytic effect of salmeterol in hormone-induced preterm labor in the rat in vivo. Am.J.Obstet.Gynecol. 2008; 198: 319.el-5. Go to original source... Go to PubMed...
    17. Jakovljevic M, Varjacic M, Jankovic SM. Cost-effectiveness of ritodrine and fenoterol for treatment of preterm labor in a low-middle-income country: a case study. Value Health, 2008: 11: 149-153. Go to original source... Go to PubMed...
    18. Juon AM, Nikolaje-Kuhn W, Burkhardt F, et al. Nifedipine gastrointestinal therapeutic systém (GITS) as an alternative to slowrelease for tocolysis-tolerance and pharmacokinetic profile. Eur.J.Obstet.Gynaecol. 2008; 140: 27-32. Go to original source... Go to PubMed...
    19. Stanley FJ, Crowther C. Antenatal magnesium sulfate for neuroprotection for preterm birth? N.Engl.J.Med., 2008; 28 August: 962-963. Go to original source... Go to PubMed...
    20. Effectivenes and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group. Br.J.Obstet.Gynaecol. 2001; 108: 133-142.
    21. Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Library 2002; 3.
    22. Moutquin JM, Herman D, Cohen H, et al. Double - blind, randomozed, controlled trial of atosiban and ritodrine in the treatment of preterm labor: A multicenter effectiveness and safety study. Am.J.Obstet.Gynec 2000; 182: 1191-1199. Go to original source... Go to PubMed...
    23. Lamont RF. Evidence-based labour ward guidelines for the diagnosis,management and treatment of spontaneous preterm labour. J.Obstet.Gynaecol. 2003; 23: 469-478. Go to original source... Go to PubMed...
    24. Roztočil A. Tokolytika. Moderní gynekologie a porodnictví 2004; 13: 298-307.

    Return to the content


    Clinical Pharmacology and Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.